Corcept Therapeutics Inc (CORT)
24.52
-0.54
(-2.15%)
USD |
NASDAQ |
May 03, 16:00
24.98
+0.46
(+1.88%)
After-Hours: 20:00
Corcept Therapeutics Stock Buybacks (Quarterly): 0.00 for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 145.43M |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | |
December 31, 2021 | 207.50M |
September 30, 2021 | 25.77M |
June 30, 2021 | 29.17M |
March 31, 2021 | 33.54M |
December 31, 2020 | 9.67M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.275M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 17.42M |
March 31, 2019 | 13.56M |
December 31, 2018 | 14.75M |
September 30, 2018 | 8.904M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 42.44M |
September 30, 2011 | -0.283M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
207.50M
Maximum
Dec 2021
27.58M
Average
--
Median
Sep 2019
Stock Buybacks (Quarterly) Benchmarks
Ultragenyx Pharmaceutical Inc | -326.46M |
Alnylam Pharmaceuticals Inc | -- |
Catalyst Pharmaceuticals Inc | 0.00 |
United Therapeutics Corp | 1.00B |
XOMA Corp | -- |